Upload
willow
View
43
Download
4
Embed Size (px)
DESCRIPTION
MLAB 1415: Hematology Keri Brophy- M artinez. Anemia Part Three. RBC Shape Variations. Alterations in the shape of the RBC is called poikilocytosis. Target Cells (Codocytes). Occur due to an increased red blood cell surface area. - PowerPoint PPT Presentation
Citation preview
MLAB 1415: HematologyKeri Brophy-Martinez
AnemiaPart Three
RBC Shape VariationsAlterations in the shape of the
RBC is called poikilocytosis.
2
Target Cells (Codocytes) Occur due to an
increased red blood cell surface area.
Appear as "targets" on peripheral blood smear. Have a pale central area with most of the hemoglobin around the rim of the cell.
Are always hypochromic.
3
Target Cells (Codocytes)
Mechanism in formation is related to excess membrane cholesterol and phospholipid, and to decreased cellular hemoglobin.
Osmotic fragility is decreased.
4
So what is Osmotic Fragility?It is a test to measure RBC
resistance to hemolysisThe quicker the hemolysis
occurs, the greater the osmotic fragility
What affects osmotic fragility?◦Surface to volume ratio◦Cell membrane permeability
Target Cells (Codocytes) Seen in patients with:
◦ Liver disease ◦ Hemoglobin C Disease or Trait ◦ Post-splenectomy ◦ Iron Deficiency Anemia ◦ Any Hemoglobin Abnormality◦ Can be artifactual
6
Spherocytes
Have a low surface-to-volume ratio.
Smaller than normal red cell; hemoglobin relatively concentrated; and, have no area of central pallor.
Shape change is irreversible.
7
SpherocytesSeveral
mechanisms for formation, but all involve loss of membrane; aging, antibody coating or genetic defect
Is the final stage for red cells before they are sequestered in the spleen.
8
SpherocytesSeen in patients with:
◦Activated complement ◦Immune Hemolytic Anemia ◦Hereditary Spherocytosis ◦Post-Transfusion
9
Wait! What is Complement?Complement refers to a complex set
of 14 distinct serum proteins that are involved in three separate pathways of activation.
Major Functions◦Promote the inflammatory response
by opsonization which enhances susceptibility of coated cells to phagocytosis.
◦Alter biological membranes to cause direct cell lysis.
Ovalocytes and Elliptocytes
Ovalocytes may appear normochromic or hypochromic; normocytic or microcytic.
Hemoglobin concentrated at both endsExact mechanism of formation unknown.
11
Ovalocytes and Elliptocytes
Ovalocytes associated with: ◦ Myelodysplastic
Syndromes ◦ Thalassemias ◦ Megaloblastic Processes
Elliptocytes associated with:◦ Iron Deficiency Anemia ◦ Hereditary Elliptocytosis ◦ Idiopathic Myelofibrosis
12
StomatocytesRed cell of
normal sizeSlit-like central
area of pallor Exact
mechanism of formation unknown
Usually artifactual
Increased osmotic fragility
13
StomatocytesAssociated with following disorders:
◦ Hereditary Stomatocytosis ◦ Hemolytic, Acute Alcoholism ◦ Rh Null Phenotype
14
Sickle Cells (Drepanocytes)
Have at least one pointed end.
Surface area of cell much greater than normal cell.
15
Sickle Cells (Drepanocytes)
Low oxygen tension causes hemoglobin to polymerize, forming tubules that line up in bundles to deform cell.
Most sickle cells can revert back to normal shape when oxygenated.
16
Sickle Cells (Drepanocytes) Associated with the following disorders: ◦Sickle Cell Anemia ◦Hemoglobin C Disease
17
AcanthocytesNormal or
slightly smaller size
Possess 3-12 thorny projections of uneven length along periphery of cell membrane.
Projections are blunt 18
Acanthocytes
Specific mechanism of formation unknown.
Contain increased cholesterol-to-phospholipid ratio.
Surface area increased
Susceptible to removal by spleen
19
AcanthocytesPossible pathologies include:
◦ Alcohol Intoxication ◦ Pyruvate Kinase Deficiency ◦ Congenital Abetalipoproteinemia ◦ Vitamin E Deficiency ◦ Post-Splenectomy
20
Fragmented CellsIncludes:
◦ Burr Cells◦ Helmet Cells◦ Schistocytes
Fragmentation is defined as a loss of a piece of cell membrane that may or may not contain hemoglobin.
21
Fragmented Cells
Two pathways that lead to fragmentation:
◦ Alteration of normal fluid circulation (vasculitis, malignant hypertension, heart valve replacement).
◦ Intrinsic defects of red cell that make it less deformable (spherocytes and antibody-covered red cells).
22
Prominent MorphologyFragmented Cells
Possible Pathology
Burr Cells
Renal diseas
e
Liver Diseas
eBurns
Schistocytes
Prosthetic
Heart Valve
Microangiopa
thic Hemol
ytic Anemi
a
DIC
TTP
HUS
Clostridial
Infections
Helmet Cells
G6PD Deficiency
Pulmonary Emboli
Burr Cells (Echinocytes)Red cells with
10-30 evenly spaced spicules over the surface of the cell.
Normocytic and normochromic.
In large numbers, are an artifact of sample contamination. 24
Burr Cells (Echinocytes)
"True" burr cells occur in small numbers in uremia, heart disease, stomach cancer, bleeding peptic ulcers, and in patients with untreated hypothyroidism.
Seen in liver disease, renal disease, and burn patients.
May occur in any situation that causes change in tonicity of intravascular fluid (dehydration). 25
Helmet Cells (Bite Cells) Usually have two
projections surrounding an empty area of red cell membrane.
Looks as if cell has had a bite taken out of it.
Caused by spleenic pitting and impalement of the RBC on fibrin strands
26
Helmet Cells (Bite Cells)
In conditions where red cells have large inclusion bodies (such as Heinz bodies
G6PD deficiencyMay be seen in
patients with pulmonary emboli, and disseminated intravascular coagulation (DIC)
27
SchistocytesExtreme cell fragmentationCell is missing
whole pieces of membrane.
Causes bizarre shapes of red cells.
28
Schistocytes
Caused by loss of membrane by mechanical means
See in patients with microangiopathic hemolytic anemia, DIC, heart valve surgery, or severe burns.
29
Teardrop CellsAppear as pear-
shaped cells. Length of tail varies. May be microcytic, normocytic, or macrocytic.
Exact formation process unknown. Commonly seen in red cells that contain large inclusion bodies.
30
Teardrop Cells
Most commonly seen in idiopathic myelofibrosis, thalassemia, and iron deficiency anemia.
31
ReferencesHarmening, D. M. (2009). Clinical
Hematology and Fundamentals of Hemostasis. Philadelphia: F.A Davis.
McKenzie, S. B., & Williams, J. L. (2010). Clinical Laboratory Hematology . Upper Saddle River: Pearson Education, Inc.
http://www.ezhemeonc.com/index.php/hematological-disorders/
http://www.wiwe.net/irene/lab/chemheme/heme/microscope/stomatocyte.htm
http://home.ccr.cancer.gov/oncology/oncogenomics/WEBHemOncFiles/Review%20of%20Terms.html